News - Mergers & Acquisitions, Markets & Marketing

Filter

Popular Filters

1 to 25 of 36 results

Growing Indian pharma market provides incentives for foreign acquisitions

20-01-2014

A recent IMS Institute for Healthcare Informatics global study has revealed that greater access to medicines…

Asia-PacificIndiaMarkets & MarketingMergers & AcquisitionsPharmaceutical

Report: M&A worth $11 billion in third quarter while Russian market shows promise

Report: M&A worth $11 billion in third quarter while Russian market shows promise

06-11-2013

PricewaterhouseCoopers (PwC) has released its quarterly Life Sciences Deals Insights Quarterly for the…

BiotechnologyEuropeMarkets & MarketingMergers & AcquisitionsPharmaceutical

Hikma sets up JV for entering Ethiopian pharma market

Hikma sets up JV for entering Ethiopian pharma market

18-09-2013

Jordon-headquartered drugmaker Hikma Pharmaceuticals (LSE: HIK) says that it has signed a 50:50 joint…

GenericsHikma PharmaceuticalsMarkets & MarketingMergers & AcquisitionsMIDROC PharmaceuticalsRest of the World

Fresenius Kabi sets up JV for IV generics in Indonesia

20-08-2013

Germany-based Fresenius Kabi, part of the Fresenius Group (FRE: Xetra) has formed a joint venture with…

Asia-PacificFreseniusFresenius KabiGenericsMarkets & MarketingMergers & AcquisitionsSoho Global Health

Alliance Boots and Walgreens expansion into China an "obvious next step," says EIU analyst

10-06-2013

Following the news that Alliance Boots and the USA's Walgreen, which initially took a 45% stake in the…

Alliance BootsAsia-PacificMarkets & MarketingMergers & AcquisitionsPharmaceuticalWalgreens

ISTA Pharma pleads guilty to federal felony charges in $33.5 million settlement; parent Bausch & Lomb a Valeant takeover target?

27-05-2013

US drugmaker ISTA Pharmaceuticals has pleaded guilty to conspiracy to introduce a misbranded drug into…

Bausch & LombISTA PharmaceuticalLegalMarkets & MarketingMergers & AcquisitionsNorth AmericaPharmaceuticalValeant PharmaceuticalsXibrom

Alliance Boots to build up interest in China

07-05-2013

According to the Financial Times, Stefano Pessina, executive chairman of Alliance Boots, is looking to…

Alliance BootsAsia-PacificMarkets & MarketingMergers & AcquisitionsPharmaceuticalWalgreens

OPKO Health acquires 10% stake in Russia's Pharmsynthez

19-04-2013

USA-based OPKO Health (NYSE: OPK) says it has acquired an approximate 10% stake in OAO Pharmsynthez (MICEX:…

EuropeLicensingMarkets & MarketingMergers & AcquisitionsOPKO HealthPharmaceuticalPharmsynthez

Analysis of China government incentives for pharma

27-03-2013

China remains an attractive target for pharmaceutical research and manufacturing, and major players from…

Asia-PacificLicensingMarkets & MarketingMergers & AcquisitionsPatentsPharmaceutical

Aggressive strategies confirm Big Pharma's Indian interest

27-01-2013

The increasing number of consolidations and in-licensing agreements between multinational corporations…

Asia-PacificLicensingMarkets & MarketingMergers & AcquisitionsPharmaceutical

Norgine and SpePharm set up JV to commercialize portfolio of drugs

18-12-2012

Independent Dutch firm Norgine BV and fellow Amsterdam-based SpePharm Holding BV have concluded a broad…

Markets & MarketingMergers & AcquisitionsNorginePharmaceuticalSpePharma

India's Elder Pharma to enter EU markets; comment on GSK Indian OTC moves

26-11-2012

Indian drugmaker Elder Pharmaceuticals says it is ready to enter the European Union market following…

Asia-PacificdiosminElder PharmaceuticalsEuropeGenericsGlaxoSmithKlineMarkets & MarketingMergers & AcquisitionsPharmaceuticalRegulation

Impax in deal with Perrigo; Cipla eyes South Africa acquisition

22-11-2012

Impax Laboratories (Nasdaq: IPXL) said yesterday that it plans to collaborate with fellow US drugmaker…

CiplaCipla MedproGenericsImpax LaboratoriesMarkets & MarketingMergers & AcquisitionsNorth AmericaPerrigoResearchRest of the World

Otsuka Pharma sets up joint venture in Turkey

07-11-2012

Otsuka Pharmaceutical (TYO: 4768), a mid-size Japanese drugmaker, and Abdi ����¯�¿�½���¯���¿���½������¯������¿������½����¯�¿�½���¯���¿���½����¯�¿�½������°brahim…

Abdi IbrahimEuropeMarkets & MarketingMergers & AcquisitionsOtsukaPharmaceutical

Analyst insight: Sanofi eyes Columbia, Indonesia and Vietnam

20-09-2012

Emerging markets, BRIC countries are words that have recently risen to prominence in a majority of pharmaceutical…

Asia-PacificLicensingMarkets & MarketingMergers & AcquisitionsPharmaceuticalSanofiSouth America

Japan's vulnerable pharma companies, by P Reed Maurer

12-09-2012

Once upon a time Japan's pharma companies could be compared to a convoy of ships. The big and small,…

Asia-PacificLicensingManagementMarkets & MarketingMergers & AcquisitionsPharmaceutical

Pharmaceutical supply chain in Japan sees squeezed margins

19-07-2012

Pressures felt in Japan as a result of the country's aging population, drug price revisions and patent…

Asia-PacificBiotechnologyFinancialMarkets & MarketingMergers & AcquisitionsPharmaceuticalPricing

Strides Arcolab unit enters Canada's injectable generics market via JV

16-07-2012

Agila Specialties Pharma Canada, which is part of the injectable drug division of Indian generic drugmaker…

Agila SpecialitesAgila-JampGenericsJamp PharmaMarkets & MarketingMergers & AcquisitionsNorth AmericaStrides Arcolab

Adcock Ingram expands in Indian pharma market buying Cosme Farma brands

10-07-2012

South Africa's largest health care company Adcock Ingram (AIP: SJ) says it has reached an agreement to…

Adcock IngramCosme FarmaMarkets & MarketingMergers & AcquisitionsPharmaceutical

S&N launches new biologics firm, Bioventus, with focus on active orthopaedic healing

08-05-2012

Bioventus, a new company providing active orthopaedic healing, launched yesterday following the finalization…

Anti-Arthritics/RheumaticsBiotechnologyBioventusMarkets & MarketingMergers & AcquisitionsSmith & Nephew

Global generic drug markets will grow to $221 billion by 2016; Espicom

29-04-2012

The economic recession has been a double-edged sword for the international generic drugs business. Driven…

GenericsGlobalMarkets & MarketingMergers & AcquisitionsPricing

Sigma-Aldrich acquires Research Organics; opens new facility in China

16-04-2012

USA-headquartered Sigma-Aldrich (Nasdaq: SIAL) has acquired all outstanding shares of Cleveland, Ohio-based,…

Asia-PacificGenericsMarkets & MarketingMergers & AcquisitionsNorth AmericaPharmaceuticalResearch OrganicsSigma-Aldrich

Actavis reportedly to be acquired by Watson; debuts generic Zomig

22-03-2012

Icelandic generic drugmaker Actavis is said to be in talks to be acquired by US peer Watson Pharmaceuticals…

ActavisAstraZenecaEuropeGenericsMarkets & MarketingMergers & AcquisitionsNeurologicalPatentsWatson PharmaceuticalsZolmitriptanZomig

1 to 25 of 36 results

Back to top